Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of JNS024ER in Japanese Subjects With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia

NCT01124617 is registered in ClinicalTrials.gov with Janssen Pharmaceutical K.K. as lead sponsor.

NCT NCT01124617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01124617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of JNS024ER in Japanese Subjects With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia
Lead sponsor
Janssen Pharmaceutical K.K.
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2010
Completion date
April 30, 2011
Enrollment
91 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic neuropathies, neuralgia, pain, postherpetic neuralgia